Agalsidase Alfa
ATC A16AB03 · 8 markets · 10 records
GB 2 records · 2 shown of 2
- 1 mg/1 mLinjectionReplagal 1mg/1ml solution for infusion vials
- 3.5 mg/3.5 mLinjectionReplagal 1mg/1ml solution for infusion vials
AU 2 records · 1 shown of 1
- 1 mg/mLinjectionREPLAGAL agalsidase alfa ghu 3.5mg/3.5mL concentrated injection vial
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
CA 1 records · 1 shown of 1
- 1 mgliquidREPLAGAL
SG 1 records · 1 shown of 1
- 1 mg/mLinjectionREPLAGAL CONCENTRATE FOR SOLUTION FOR INFUSION 1 MG/ML
TW 1 records · 1 shown of 1
- 1 mginjectionREPLAGAL 1MG/ML CONCENTRATION FOR SOLUTION FOR INFUSION利甫蓋素濃縮注射液1毫克/毫升
HK 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 1 records · 1 shown of 1
- 1 mg/1 mLinjectionREPLAGAL 1 mg/ml, solution à diluer pour perfusion
| Strength / form / release | GB | CA | AU | SG | TW | HK | EU | FR |
|---|---|---|---|---|---|---|---|---|
| 1 mg/1 mL injection | Replagal 1mg/1ml solution for infusion vials | REPLAGAL 1 mg/ml, solution à diluer pour perfusion | ||||||
| 1 mg injection | REPLAGAL 1MG/ML CONCENTRATION FOR SOLUTION FOR INFUSION 利甫蓋素濃縮注射液1毫克/毫升 | |||||||
| 1 mg/mL injection | REPLAGAL agalsidase alfa ghu 3.5mg/3.5mL concentrated injection vial | REPLAGAL CONCENTRATE FOR SOLUTION FOR INFUSION 1 MG/ML | ||||||
| 1 mg liquid | REPLAGAL | |||||||
| 3.5 mg/3.5 mL injection | Replagal 1mg/1ml solution for infusion vials | |||||||
unknown | REPLAGAL | REPLAGAL CONCENTRATE FOR SOLUTION FOR INFUSION 3.5MG/3.5ML | REPLAGAL |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in CA and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en CA que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 CA 有记录(未在本表显示)。 另有 1 個規格/劑型僅在 CA 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.